Insider Trading & Ownership of Joshua N. Silverman

Location: New York, NY
Summary: The estimated net worth of Joshua N. Silverman is at least $1,657,975 dollars as of 07 Jan 2026. Joshua N. Silverman is the Executive Chairman, Director of TAO Synergies Inc. and owns shares of Synaptogenix, Inc. (SNPX) stock worth about $626.7K. Joshua N. Silverman is the Executive Chairman, Director of Q/C TECHNOLOGIES, INC. and owns shares of TNF Pharmaceuticals, Inc. (TNFA) stock worth about $435.1K. Joshua N. Silverman is the CEO and President, Director of PharmaCyte Biotech, Inc. and owns shares of PharmaCyte Biotech, Inc. (PMCB) stock worth about $397.7K. Joshua N. Silverman is the Chief Executive Officer, Director of StableX Technologies, Inc. and owns shares of AYRO, Inc. (AYRO) stock worth about $154.3K. Joshua N. Silverman is the Director of Petros Pharmaceuticals, Inc. and owns shares of Petros Pharmaceuticals, Inc. (PTPI) stock worth about $44.2K.
Signature: /s/ Joshua N. Silverman
All Insider Reports: All Insider Reports

Notify me when Joshua N. Silverman files a new Insider Trading report.

Ownership of Joshua N. Silverman

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SNPX	Synaptogenix, Inc.	Executive Chairman, Director	$626,703			06 Aug 2025
TNFA	TNF Pharmaceuticals, Inc.	Executive Chairman, Director	$435,126			14 Nov 2025
PMCB	PharmaCyte Biotech, Inc.	CEO and President, Director	$397,694	+$80,476	+25%	05 Jan 2026
AYRO	AYRO, Inc.	Chief Executive Officer, Director	$154,298			31 Oct 2025
PTPI	Petros Pharmaceuticals, Inc.	Director	$44,154			02 Jan 2026
FEMY	FEMASYS INC	Director				25 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.